1. 三维可视化技术辅助肝细胞癌消融治疗有效性及安全性的 Meta 分析.
- Author
-
李开富, 唐永成, 唐 浩, 张 玺, 高本见, 罗 德, 苏 松, 李 波, and 杨小李
- Abstract
Objective. To systematically evaluate the efficacy and safety of three-dimensional visualization technology in assisting ablation therapy for hepatocellular carcinoma. Methods This study was conducted according to PRISMA guidelines, with a PROSPERO registration number of CRD42023488398. PubMed, Embase, Web of Science, the Cochrane Library, CNKI. Wandang Data, VIP, and CBM weze searched for Chinese and English articles on three-dimensional visualization technology in assisting ablation therapy for hepatocellular carcinoma published up to Manh 2023. After quality assessment and data extraction of the studies included, RevMan 5.4 software was used to perform the meta-analyses. Results A total of 11 studies were included. with 972 patients in total, among whom 447 underwent ablation assisted by three-dimensional visualization technology (30 group) and 525 underwent ablation assisted by traditional two-dimensional imaging technology (20 goup). The meta-analysis showed that compared with the 210 group, the 30 group had significantly higher success rate of fust-time ablation treatment (odds ratio [OR]= 5.43, 95% confidence interval (CI): 2.64-11.18, P<0.001), technical efficiency (OR=6.15, 95%CI: 3.23-11.70, P<0.001), and complete ablation rate (OR-2.50, 95%(7: 1.08-5.78. P = 0.03 ). as well as significantly lower incidence rate of major complications (OR=0.45, 95% CI, 0.24-0.87, P-002), local recurrence rate (OR=0.35, 95%CI: 0.17-0.72, P = 0.004 ). and local tumor progression rate (0R = 0.29), 95%C7; 0.16-0.50, /<0.001), while there was no significant difference in the incidence rate of mild complications between the two groups (P > 0.05) Conclusion Three-dimensional visualization technology is safe and feasible in assisting ablation therapy for hepatocellular carcinoma and can improve ablation rate and reduce the incidence tate of serious complications. local recurrence rate, and local tumor progression rate, thereby showing an important application value in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF